Market movement
In 2024, polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues: somatotropin, its derivatives and structural analogues trade exhibited significant decline, with global flows reaching $591,107,283 and a three-year compound annual growth rate of -3.6% (five-year: +10.0%). The all-time peak of $2,112,608,890 was recorded in 2022; the current level is 72% below that high-water mark.
Over the 30-year observation window (1995–2024), 55% of years recorded positive growth, indicating a mildly upward trajectory with periodic contractions. Trend momentum is steady (+2.1% acceleration).
